PURPOSE: To examine patterns of health care utilization and costs among cystic fibrosis (CF) patients with pulmonary infections. DESIGN: Retrospective administrative claims database analysis. METHODOLOGY: We used administrative claims data (including both medical and pharmacy claims) to examine health care utilization and costs among CF patients with pulmonary infections over one year. We conducted a subgroup analysis in which we examined selected outcome measures among patients with tobramycin for inhalation (TIS) prescriptions by the number of TIS prescriptions filled. PRINCIPAL FINDINGS: Among 1,064 CF patients identified with pulmonary infections, 80% had at least one CF-related office visit, 34% had a CF-related hospital stay, and 95% filled at least one prescription over one year. Total annual CF-related health care costs averaged $29,000 plus $20,000 for prescription drugs. In the subgroup analysis, there was a trend towards longer lengths of stay and higher inpatient costs with fewer numbers of TIS prescriptions filled. CONCLUSION: CF patients with pulmonary infections have substantial levels of health care utilization and costs.
PURPOSE: To examine patterns of health care utilization and costs among cystic fibrosis (CF) patients with pulmonary infections. DESIGN: Retrospective administrative claims database analysis. METHODOLOGY: We used administrative claims data (including both medical and pharmacy claims) to examine health care utilization and costs among CF patients with pulmonary infections over one year. We conducted a subgroup analysis in which we examined selected outcome measures among patients with tobramycin for inhalation (TIS) prescriptions by the number of TIS prescriptions filled. PRINCIPAL FINDINGS: Among 1,064 CF patients identified with pulmonary infections, 80% had at least one CF-related office visit, 34% had a CF-related hospital stay, and 95% filled at least one prescription over one year. Total annual CF-related health care costs averaged $29,000 plus $20,000 for prescription drugs. In the subgroup analysis, there was a trend towards longer lengths of stay and higher inpatient costs with fewer numbers of TIS prescriptions filled. CONCLUSION: CF patients with pulmonary infections have substantial levels of health care utilization and costs.
Authors: Ankur Pandya; Stephen Sy; Sylvia Cho; Sartaj Alam; Milton C Weinstein; Thomas A Gaziano Journal: Med Decis Making Date: 2017-05-10 Impact factor: 2.583
Authors: Zachary M Sellers; Beate Illek; Miriam Frankenthal Figueira; Gopika Hari; Nam Soo Joo; Eric Sibley; Jackson Souza-Menezes; Marcelo M Morales; Horst Fischer; Jeffrey J Wine Journal: PLoS One Date: 2017-12-27 Impact factor: 3.240